Quick Answer
Zhengye Biotechnology Holding Ltd reported Operating Income Loss of $16.44 million for the year ending 2024.
- Zhengye Biotechnology Holding Ltd showed a decrease of -63.5% in Operating Income Loss from 2023 to 2024.
- This data is from Zhengye Biotechnology Holding Ltd's annual report (Form 10-K), filed with the SEC on July 3, 2025.
- XBRL data for this metric is available from 2022 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2022 to 2024), Zhengye Biotechnology Holding Ltd's Operating Income Loss has declined by 75.0%.
- Historical annual values: Fiscal year 2024: $16.44 million | Fiscal year 2023: $44.99 million | Fiscal year 2022: $65.83 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: